- Title: Subtitle
- Real-World Efficacy Outcomes of Ciltacabtagene Autoleucel in Relapsed Refractory Multiple Myeloma: A Comparative Study with the Cartitude-1 Trial
- Creators
- Ishita Kamboj - University of Kansas Medical CenterDarryl Chang - Levine Cancer InstituteAlma Habib - The Ohio State UniversityAndrew Vegel - University of IowaEmily Struble - University of IowaHira Shaikh - University of IowaChristopher Strouse - University of IowaJames A Davis - MUSC Hollings Cancer CenterAliya Rashid - University of Kansas Medical CenterKevin Graf - Medical University of South CarolinaKimberly M Green - Medical University of South CarolinaMuhammad Umair Mushtaq - University of Kansas Medical CenterZahra Mahmoudjafari - University of Kansas Medical CenterHamza Hashmi - Medical University of South CarolinaJoseph P. McGuirk - University of Kansas Medical CenterAl-Ola AbdallahShebli Atrash - Levine Cancer InstituteAbdullah Mohammad Khan - The Ohio State UniversityNausheen Ahmed - University of Kansas Medical Center
- Resource Type
- Abstract
- Publication Details
- Blood, Vol.144(Supplement 1), pp.2411-2411.2
- DOI
- 10.1182/blood-2024-199187
- ISSN
- 0006-4971
- eISSN
- 1528-0020
- Publisher
- ELSEVIER
- Language
- English
- Date published
- 11/05/2024
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984770787702771
Abstract
Real-World Efficacy Outcomes of Ciltacabtagene Autoleucel in Relapsed Refractory Multiple Myeloma: A Comparative Study with the Cartitude-1 Trial
Blood, Vol.144(Supplement 1), pp.2411-2411.2
11/05/2024
DOI: 10.1182/blood-2024-199187
Details
Metrics
8 Record Views